Big Pharma's Q3 2010 Earnings Report

The third quarter was a mixed bag for Big Pharma. After recalls and lawsuits, many companies took hits to their quarterly earnings, but most still came ahead of analysts' expectations. For highlights of the ups and downs of the top 10 companies in pharma (according to 2009 revenue), check out our list, or click through to a specific company.

1. Johnson & Johnson
2. Pfizer
3. Roche
4. GlaxoSmithKline
5. Novartis

6. Sanofi-Aventis
7. AstraZeneca
8. Abbott Laboratories
9. Merck
10. Bayer Healthcare


Suggested Articles

The second of AbbVie’s highly anticipated 2019 blockbuster candidates is here: Its crucial Humira follow-up, Rinvoq.

Bristol-Myers Squibb’s takeover of Celgene hasn’t always gone smoothly, but now a once-left-for-dead centerpiece of that deal is ready to launch.

Investors sued Novo Nordisk in Denmark, claiming it misled the public about trouble plaguing its insulin franchise—and demanding $1.75B in damages.